© 2020 MJH Life Sciences and Neurology Live. All rights reserved.
© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
June 22, 2020
The “time is brain” mantra continues to drive innovation in a specialty that will not settle for mediocrity.
June 23, 2020
New drug classes and formulations may help hold off breakthrough activity as the research community works to optimize levodopa delivery and absorption.
June 24, 2020
Biomarkers in the cerebrospinal fluid and blood could hold the key to early diagnosis of Alzheimer disease.
June 25, 2020
A whole-patient approach to management, coupled with new, more targeted treatments, may help reduce the incidence of medication overuse headache.
June 29, 2020
In this Peer Exchange, sleep experts provide insight into the latest narcolepsy treatments and areas that require further research.
June 30, 2020
An in-depth look into the expanding landscape of multiple sclerosis treatments that target bruton tyrosine kinase.
July 01, 2020
Clinical Trial in Progress
Biohaven’s verdiperstat has entered a phase 3 trial for the treatment of multiple system atrophy, with a new drug application submission on the agenda for late 2021.
July 02, 2020
Andrew Russman, DO, guest editor for NeurologyLive, provides insight on how stroke care has changed during the COVID-19 pandemic.
July 03, 2020
In the wake of the COVID-19 pandemic, health care providers and patients have had to quickly adapt to new formats of care models to promote safety while retaining care standards.
July 04, 2020
Medical World News
A look at the questions you should be asking during the decision-making process of picking a telehealth vendor.